Part D Drug Data Expected To Be Available For Research Dec. 1
Executive Summary
CMS is targeting Dec. 1 as the date for opening Medicare Part D drug claims data to both government and independent researchers
You may also be interested in...
FDA Finds “Comfort Level” With Using Medicare Data For Sentinel Initiative
FDA research into the clinical accuracy and stability over time of Medicare claims data has shown it could be a reliable source of information for active product safety surveillance, according to FDA’s Judy Racoosin, scientific lead for the Sentinel Initiative within the Center for Drug Evaluation and Research.
FDA Finds “Comfort Level” With Using Medicare Data For Sentinel Initiative
FDA research into the clinical accuracy and stability over time of Medicare claims data has shown it could be a reliable source of information for active product safety surveillance, according to FDA’s Judy Racoosin, scientific lead for the Sentinel Initiative within the Center for Drug Evaluation and Research.
Group With Ties To Daschle Urges Release Of More Detailed Part D Data
A new report from the Center for American Progress highlights the potential value to comparative effectiveness research of Medicare Part D claims and performance data and urges the release of more detailed information on the program through administrative changes